Vitamin C improves endothelial dysfunction in renal allograft recipients

被引:43
作者
Williams, MJA
Sutherland, WHF
McCormick, MP
de Jong, SA
McDonald, JR
Walker, RJ
机构
[1] Univ Otago, Dept Med, Dunedin, New Zealand
[2] Univ Otago, Dept Comp Sci, Dunedin, New Zealand
关键词
antioxidants; ascorbic acid; endothelium; transplantation;
D O I
10.1093/ndt/16.6.1251
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Endothelial function is impaired in renal allograft recipients but the effects of antioxidant vitamin therapy on endothelial function in such patients is unknown. Methods, Thirteen renal allograft recipients were randomized to vitamin C or placebo in a double blind cross-over study design. Flow-mediated endothelium-dependent dilation and glyceryltrinitrate-induced endothelium-independent dilation of the brachial artery were assessed before and 2 h after oral administration of 2 g vitamin C or placebo. Results, Plasma vitamin C levels increased 33.5 +/- 17.0 mu mol/l to 98.8+/-60.2 mu mol/l after treatment (P=0.0001). Endo thelium-dependent dilation improved (from 1.6 +/- 2.6 to 4.5 +/- 2.5%) after vitamin C administration but was unchanged after placebo (1.9 +/- 1.5 to 1.8 +/- 2.5%; P = 0.003 for vitamin C vs placebo). There was no significant change in endothelium-independent dilation in response to vitamin C. Vitamin C was also associated with a significant increase in the lag time in dilute serum oxidation (P = 0.001). Conclusions. Vitamin C acutely improves mediated, endothelium-dependent dilation increases the resistance of lipoproteins in ( serum to oxidation in renal transplant recipients.
引用
收藏
页码:1251 / 1255
页数:5
相关论文
共 20 条
  • [1] Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans
    Anderson, TJ
    Meredith, IT
    Charbonneau, F
    Yeung, AC
    Frei, B
    Selwyn, AP
    Ganz, P
    [J]. CIRCULATION, 1996, 93 (09) : 1647 - 1650
  • [2] NONINVASIVE DETECTION OF ENDOTHELIAL DYSFUNCTION IN CHILDREN AND ADULTS AT RISK OF ATHEROSCLEROSIS
    CELERMAJER, DS
    SORENSEN, KE
    GOOCH, VM
    SPIEGELHALTER, DJ
    MILLER, OI
    SULLIVAN, ID
    LLOYD, JK
    DEANFIELD, JE
    [J]. LANCET, 1992, 340 (8828) : 1111 - 1115
  • [3] Mechanisms of disease - Antioxidants and atherosclerotic heart disease
    Diaz, MN
    Frei, B
    Vita, JA
    Keaney, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) : 408 - 416
  • [4] Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease
    Gokce, N
    Keaney, JF
    Frei, B
    Holbrook, M
    Olesiak, M
    Zachariah, BJ
    Leeuwenburgh, C
    Heinecke, JW
    Vita, JA
    [J]. CIRCULATION, 1999, 99 (25) : 3234 - 3240
  • [5] HALLIWELL B, 1992, J LAB CLIN MED, V119, P598
  • [6] Flow-mediated vasodilation and distensibility of the brachial artery in renal allograft recipients
    Hausberg, M
    Kisters, K
    Kosch, M
    Rahn, KH
    Barenbrock, M
    [J]. KIDNEY INTERNATIONAL, 1999, 55 (03) : 1104 - 1110
  • [7] Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin
    Huang, A
    Vita, JA
    Venema, RC
    Keaney, JF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (23) : 17399 - 17406
  • [8] Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease
    Levine, GN
    Frei, B
    Koulouris, SN
    Gerhard, MD
    Keaney, JF
    Vita, JA
    [J]. CIRCULATION, 1996, 93 (06) : 1107 - 1113
  • [9] Endothelial dysfunction in renal transplant recipients maintained on cyclosporine
    Morris, STW
    McMurray, JJV
    Rodger, RSC
    Farmer, R
    Jardine, AG
    [J]. KIDNEY INTERNATIONAL, 2000, 57 (03) : 1100 - 1106
  • [10] *NIH, 1991, US REN DAT SYST US R